Treatment of recurring cutaneous drug reactions in patients with human immunodeficiency virus 1 infection: a series of 3 cases.
Dolev
Jacqueline
J
University of California, San Francisco 94110, USA.
Reyter
Ilya
I
Maurer
Toby
T
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology*; D005500:Follow-Up Studies; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D012008:Recurrence; D018570:Risk Assessment; D012494:Sampling Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome
D011241:Prednisone